Ferring Looks To Chop Down Direct Purchaser Suits

Law360, New York (September 12, 2008, 12:00 AM EDT) -- An attorney for Ferring Pharmaceuticals Inc. argued Monday that if direct purchasers were allowed to bring an antitrust case alleging that the company kept generic drugs off the shelves by fraudulently acquiring a patent, then it would open up the floodgates to a massive amount of litigation.

Douglas Wald, a partner with Arnold & Porter LLP, told a three-judge panel of the U.S. Court of Appeals for the Second Circuit that a victory for the plaintiffs would allow anyone to attack a patent under antitrust laws...
To view the full article, register now.